42Bio is a startup company in Gainesville, Florida
that spun out of the University of Florida.
42Bio’s mission is to develop and implement regenerative medicine technologies to advance human and veterinary health.
The objective of 42Bio is to apply our magnetic and biomolecule technologies to address unmet needs in clinical and veterinary disease and injury. We aim to advance these technologies to make meaningful and rigorously-studied products that benefit both clinical and scientific communities.